https://pubmed.ncbi.nlm.nih.gov/10839587/
Decreased exposure to saquinavir in HIV-1-infected patients after long-term antiretroviral therapy...
The exposure to saquinavir decreased over time in HIV-infected patients on stable antiretroviral therapy. These data suggest that regular monitoring of plasma...
https://pubchem.ncbi.nlm.nih.gov/bioassay/1209144
AID 1209144 - Arithmetic mean of Terminal elimination half-life of saquinavir mesylate following...
BioAssay record AID 1209144 submitted by ChEMBL: Arithmetic mean of Terminal elimination half-life of saquinavir mesylate following oral repeat dosing of 1000...
arithmetic mean
https://adisinsight.springer.com/drugsafety/800790061?error=cookies_not_supported&code=4494671f-fe72-4f2d-b0f7-edb65acb4f75
Saquinavir may cause less metabolic disorders than other protease inhibitors - AdisInsight
The incidence of metabolic abnormalities during saquinavir soft gelatin capusle-based highly active antiretroviral therapy (HAART) may be lower than that
metabolic disordersprotease inhibitorssaquinavirmaycause
https://sco.wikipedia.org/wiki/Saquinavir?action=edit&redlink=1
Makin Saquinavir - Wikipedia
makinsaquinavirwikipedia
https://adisinsight.springer.com/patents/800001184
Saquinavir - AdisInsight
saquinaviradisinsight
https://researchconnect.buffalo.edu/en/publications/effect-of-saquinavirritonavir-1000100-mg-bid-on-the-pharmacokinet/
Effect of saquinavir/ritonavir (1000/100 mg bid) on the pharmacokinetics of methadone in...